🔎 Trials Near Me

Gara Jalqabaatti › Sklerosisii Heddummaa Irra Deebi'uu fi Qabbachuu

Qorannoo klinikaalii Sklerosisii Heddummaa Irra Deebi'uu fi Qabbachuu Ameerikaa Keessatti hirmaatuu

Qorannoo 18 Sklerosisii Heddummaa Irra Deebi'uu fi Qabbachuu f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT04047628

Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

Namoota walitti qabaa jira
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT05958381

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 10 hanga 17 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06408259

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Namoota walitti qabaa jira
Umuriin 22 hanga 60 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06796504

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 40 hanga 70 · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT07758270

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

Namoota walitti qabaa jira
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06864936

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT05359653

Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis

Namoota walitti qabaa jira
Umuriin 45 hanga 89 · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT06919900

Intermittent Hypoxia in Persons With Multiple Sclerosis

Namoota walitti qabaa jira
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT06276634

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT07225361

Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study

Namoota walitti qabaa jira
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 06-Bit-2026 · NCT07376772

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Namoota walitti qabaa jira
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 23-Gur-2026 · NCT06390930

Effects of Ublituximab on Motor Functions in Multiple Sclerosis

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 09-Gur-2026 · NCT06629428

Home Based Functional Balance Intervention for Multiple Sclerosis

Namoota walitti qabaa jira
Umuriin 40 hanga 90 · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07355387

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Onk-2025 · NCT07222618

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

Namoota walitti qabaa jira
Umuriin 22 hanga 75 · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT05964829

MS-ResearchBiomarkerS

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamooKaffaltii hirmaatootaaf ibsa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Gur-2024 · NCT05204459

Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 06-Wax-2022 · NCT04458688

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.